CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache is a research paper published in Cephalalgia (2021). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Grant: PhD and interuniversity exchange fellowships
National Institutes of Health
Grant: NIH1R01NS106902
FWCI
4.28
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CGRP-targeted medication in chronic migraine - systematic review
Additional file 1 of CGRP-targeted medication in chronic migraine - systematic review
Additional file 1 of Hypersensitivity to BKCa channel opening in persistent post-traumatic headache
Additional file 1 of Hypersensitivity to BKCa channel opening in persistent post-traumatic headache